Disclosures for " Multi-Modal Correlation Analyses From a Phase 2, Open-Label Study of NE3107 in Patients With Cognitive Decline Due to Degenerative Dementias")
-
Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has stock in BioVie. An immediate family member of Dr. Palumbo has stock in Merck Research Laboratories. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
-
Jeffrey Zhang has received personal compensation for serving as an employee of Princeton Pharmatech. Jeffrey Zhang has received stock or an ownership interest from CalciMedica.
-
Ms. Mahdavi has nothing to disclose.
-
Ms. Venkatraman has nothing to disclose.
-
Mr. Becerra has nothing to disclose.
-
Mr. Haroon has nothing to disclose.
-
Ms. Jordan has nothing to disclose.
-
Ms. Rindner has nothing to disclose.
-
Mr. Surya has nothing to disclose.
-
Dr. KUHN has nothing to disclose.
-
Dr. POURAT has nothing to disclose.
-
Dr. Jordan has stock in Synaptec Network.